The CaptureSelect™ IgA Affinity Matrix has specifically been designed for the purification of human IgA from recombinant and plasma sources.
Features of this affinity matrix include:
• Platform for all human IgA, binding to IgA1, IgA2 , dimeric IgA, and S-IgA (secretory IgA) • Excellent scalability • Non-animal-derived
Free of Animal Components Our CaptureSelect™ products are affinity ligands created by a proprietary technology based on Camelid-derived single domain antibody fragments. The ligand is a 13 kDa single domain fragment comprising the 3 CDRs that form the antigen binding domain, efficiently produced by the yeast Saccharomyces cerevisiae in a production process free of animal components.
Main Characteristics:
Matrix: agarose-based, aldehyde-activated Average particle size: 65 ± 10 µm Ligand: CaptureSelect™ IgA affinity ligand Ligand coupling method: aldehyde coupling via NH2 residues of the ligand Binding capacity: ~8 g/L resin Elution conditions: 0.1 M glycine, pH 3.0 Flow characteristics: 200–400 cm/h Formulation buffer: 20%(v/v) ethanol
原厂资料：
注意事项：
For Research Use Only. Not for use in diagnostic procedures.
京公网安备11010802025653 版权所有：北京逸优科技有限公司
